Despite these limitations, the findings may provide a strong rationale for future multicenter prospective studies incorporating serial SIRT2 measurements and mechanistic investigations to clarify its role as a biomarker of renal injury and to determine whether it is involved in potentially modifiable pathophysiological pathways in diabetic nephropathy. Here, SIRT2 is linked to diabetic kidney disease.